Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Sept 18 (Reuters) — SANDOZ GROUP AG: Sandoz Receives Regulatory Approval For Generic Semaglutide In Canada, Paving Way To Expand Patient Access To Key Glp-1 Medicine Receives Regulatory Approval For Generic Semaglutide In Canada Health Canada Grants Marketing Authorisation For Sandoz Semaglutide Semaglutide Approved In
Sandoz Group AG / Key word(s): Regulatory Approval Sandoz receives regulatory approval for generic semaglutide in Canada, paving way to expand patient access to key GLP-1 medicine 18-Sep-2026 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of th